FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

385112003: Conventional release cutaneous powder (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1459290010 Cutaneous powder (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1479374014 Cutaneous powder en Synonym Active Entire term case insensitive SNOMED CT core module
2621573014 Topical powder en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660370017 Cutaneous powder (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3559622012 Conventional release cutaneous powder (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3559623019 Conventional release cutaneous powder en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous powder Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Is a Drug powder false Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Has basic dose form Powder true Inferred relationship Existential restriction modifier
Conventional release cutaneous powder Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Conventional release powder for cutaneous spray Is a False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100 unit/1 milligram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Streptokinase+streptodornase 100,000/25,000units topical powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely undecylenic acid 50 microgram/1 milligram and zinc undecylenate 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Mafenide acetate 5% powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine diacetate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Salicylic acid+boric acid 3%/5% conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous powder Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 900 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely calcium undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug) Has manufactured dose form True Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder Has manufactured dose form False Conventional release cutaneous powder Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start